JPMorgan raised the firm’s price target on iRhythm (IRTC) to $240 from $190 and keeps an Overweight rating on the shares. The company reported “another broad-based beat” and is positioned for another year of upside in 2026, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRTC: